0001127602-13-023099.txt : 20130718 0001127602-13-023099.hdr.sgml : 20130718 20130718175132 ACCESSION NUMBER: 0001127602-13-023099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130718 FILED AS OF DATE: 20130718 DATE AS OF CHANGE: 20130718 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haluska Frank CENTRAL INDEX KEY: 0001494892 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 13975560 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS, INC. STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-07-18 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001494892 Haluska Frank C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 SVP, Clinical R&D, CMO Common Stock 2013-07-18 4 S 0 6400 19.7878 D 83507 D These shares were sold to satisfy witholding tax requirements related to the vesting of performance stock units previously reported. These shares were sold pursuant to a 10b5-1 trading plan adopted by the reporting person in December 2012. /s/Edward M. Fitzgerald, Attorney-in-Fact 2013-07-18